NIH Tries to Help Patients With 'Mystery Diseases'

Tuesday, 01 Jul 2014 05:28 PM

 

  Comment  |
   Contact  |
  Print   |
    A   A  
  Copy Shortlink
The government is expanding its "mystery disease" program, funding a network at six universities around the country to help diagnose patients with diseases so rare they've been told they're undiagnosable.
 
The National Institutes of Health has evaluated hundreds of these cold-case patients in its campus research hospital as part of a pilot program since 2008. Demand is so great, there's a waiting list.

So on Tuesday, the agency announced the NIH Undiagnosed Diseases Network, a four-year, $43 million initiative to bring more doctor-detectives on board in the quest to at least put a name to more patients' puzzling symptoms, and eventually find treatments.

The centers include: Baylor College of Medicine in Houston, Duke University, Stanford University, University of California, Los Angeles, Vanderbilt University and the Harvard University teaching hospitals Brigham and Women's, Massachusetts General and Boston Children's.

The network "will focus on the rarest of disorders, often those affecting fewer than 50 people in the entire world," said Dr. Eric Green, director of NIH's National Human Genome Research Institute.

It's a field that can be "bleak and frustrating" for patients and doctors alike, said NIH program director Dr. William Gahl.

More than 3,000 patients have applied to the pilot program, which so far has enrolled about 600, NIH said. Gahl put the "solve rate" at about 25 percent. Scientists say newer, more powerful genetic technologies give hope for unraveling the cause of more of these mystery diseases.

Louise Benge of Brodhead, Kentucky, and her siblings suffer debilitating pain in their hands and legs. After she enrolled in the pilot program, researchers discovered they inherited a rare genetic defect that makes calcium build up just in the arteries that feed those limbs, making walking and other movements difficult. Now researchers are testing a medication.

"They have been really good about helping us and trying their best to figure out something for us to be able to get our life back without having all this pain," Benge told reporters Tuesday.

How the network will operate: The NIH will continue evaluating about 130 to 150 patients a year. The universities will gradually add additional ones until, by the summer of 2017, each should be admitting about 50 patients a year.

Participating patients spend a week in the designated center for head-to-toe examinations and testing. NIH said no patient would be turned away from the program because of lack of insurance although each center would decide how to handle coverage.

© Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  Comment  |
   Contact  |
  Print   |
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Food Pesticide Residue Nothing to Worry About: USDA

Saturday, 20 Dec 2014 10:26 AM

More than half of food tested by the U.S. government for pesticide residues last year showed detectable levels of pestic . . .

Beware of Holiday Allergy Triggers

Saturday, 20 Dec 2014 10:16 AM

The holidays can be anything but joyous for people with allergies when they contend with fresh trees, scented candles an . . .

Diagnose Your Kid's Ear Infection With Your iPhone

Friday, 19 Dec 2014 16:15 PM

Diagnosing your kid's ear infections might soon be as simple as taking a video on your smartphone. . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved